INSR and hyperandrogenism: However, available studies suggest that reduction of INSR function to the ∼25–50% range results in Type A Insulin Resistance (TA-IR), in which patients present with hyperinsulinemia, acanthosis nigricans, polycystic ovarian syndrome (PCOS), hirsuitism, and hyperandrogenism.